Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Essentra Plc LSE:ESNT London Ordinary Share GB00B0744359 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  7.50 2.31% 332.50 1,053,591 16:35:15
Bid Price Offer Price High Price Low Price Open Price
325.00 326.00 328.00 322.50 327.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 896.50 6.00 1.70 195.6 1,003
Last Trade Time Trade Type Trade Size Trade Price Currency
18:28:29 O 118,546 332.50 GBX

Essentra (ESNT) Latest News

More Essentra News
Essentra Investors    Essentra Takeover Rumours

Essentra (ESNT) Discussions and Chat

Essentra Forums and Chat

Date Time Title Posts
20/5/202110:35Essentra (formerly Filtrona)330

Add a New Thread

Essentra (ESNT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-06-18 17:29:46332.50118,546394,165.45O
2021-06-18 17:28:39327.472994.97O
2021-06-18 16:56:34332.509,16830,483.60O
2021-06-18 16:48:53332.4766,358220,618.45O
2021-06-18 16:41:31329.881,2324,064.08O
View all Essentra trades in real-time

Essentra (ESNT) Top Chat Posts

DateSubject
19/6/2021
09:20
Essentra Daily Update: Essentra Plc is listed in the Support Services sector of the London Stock Exchange with ticker ESNT. The last closing price for Essentra was 325p.
Essentra Plc has a 4 week average price of 303p and a 12 week average price of 287p.
The 1 year high share price is 343.40p while the 1 year low share price is currently 231.20p.
There are currently 301,682,058 shares in issue and the average daily traded volume is 604,311 shares. The market capitalisation of Essentra Plc is £1,003,092,842.85.
16/4/2021
13:31
essentialinvestor: This is significant: "...Cost actions continue to support margin improvement, paving the way of our journey to reach a 2021 margin exit rate in line with the industry average of 8-10% (barring any major unforeseen macro-economic events). Recent order book trends have been improving and we continue to believe the market will return to moderate growth in the second half of 2021 as global healthcare systems catch up on the significant backlog of prescriptions and elective surgeries..." Margins on their packaging side have been negligible for years- at last it appears we have definite progress as a result of efficiency and other efforts. Components business is highly correlated to GDP growth, with 2021 global recovery underway It should thrive longer term, particularly given recent market share gains. Whether the market is interested now ...however medium term Essentra looks well positioned.
10/3/2021
14:50
philanderer: EI, found this, it may be of help: Essentra plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now March 09, 2021 HTTPS://simplywall.st/stocks/gb/materials/lse-esnt/essentra-shares/news/essentra-plc-earnings-missed-analyst-estimates-heres-what-an
04/3/2021
15:41
philanderer: The way the shareprices have gone for SYNT and VSVS reporting today , could see ESNT around 275p early tomorrow :-(
09/11/2020
15:28
philanderer: It's taken Pfizer to get us back to the placing price :-)
12/10/2020
14:52
philanderer: Holding above the placing price anyway.
18/9/2020
10:02
philanderer: stpalm , here you go.. A total of 37,223,079 Placing Shares have been conditionally placed by Jefferies International Limited ("Jefferies") and Peel Hunt LLP ("Peel Hunt") with certain existing and new institutional investors at an issue price of 260 pence per share (the "Placing Price"). HTTPS://www.investegate.co.uk/essentra-plc--esnt-/rns/results-of-fundraise-and-total-voting-rights/202009180700023731Z/
18/9/2020
00:16
philanderer: Jefferies note (from last week)........... Essentra PLC (LON:ESNT) is doing better amidst the COVID-19 pandemic than Jefferies feared and has been upgraded by the investment bank. Jefferies new ‘buy’ rating, up from ‘hold’, comes with a 360p price target – compared to a current price of around 291p. Analyst Andy Douglas pointed to growth opportunities in the components and filters businesses, whilst he added that the packaging division has recovery potential. “Having navigated its way through COVID-19 challenges well, Essentra has proven to be less cyclical than we feared, a number of risks have not emerged, and we believe the group is well-positioned for medium-term recovery and growth,” the analyst said. “However, we believe the market neither fully appreciates nor appropriately values the medium-term growth opportunities and the EBITA margin potential. “In some cases, we do believe many of these opportunities are well-understood. We expect sentiment to change as the recovery comes through/momentum shifts, and look for the shares to re-rate.” proactiveinvestors.co.uk
17/9/2020
18:19
captain stock: 25p is the ordinary share denomination not the share price. Bid price to be confirmed. ??
15/9/2020
17:05
essentialinvestor: Hi Phil, had a very small amount before the close. Tbh, was not that impressed by the results call, which went on forever. Paul likes the sound of his own voice. ESNT may be worth more to another company. Would not rule out an equity raise here, just imv.
02/9/2020
11:40
philanderer: Morning EI. ESNT the only red one out of thirty in my lot today, but it's not a large holding :-)
Essentra share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
ESNT
Essentra
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210619 15:24:40